share_log

Revitalist Announces Cdn$3 million Private Placement Offering with Institutional Investors

Revitalist Announces Cdn$3 million Private Placement Offering with Institutional Investors

Reitist宣佈與機構投資者進行300萬加元的私募發行
Businesswire ·  2021/11/15 21:11

VANCOUVER, British Columbia--(BUSINESS WIRE)--$CALM #canadiansecuritiesexchange--NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

不列顛哥倫比亞省温哥華--(美國商業通訊社)--$CAMP#加拿大證券交易所--不分發給美國新聞通訊社或在美國傳播。

REVITALIST LIFESTYLE AND WELLNESS LTD. ("Revitalist" or the "Company") (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce that it has entered into a securities purchase agreement for a private placement of units ("Units") to institutional investors only for aggregate gross proceeds to the Company of approximately Cdn$3 million (the "Private Placement"). Pursuant to the Private Placement, the Company will issue 5,357,143 Units at a purchase price of Cdn$0.56 per Unit. Each Unit will consist of one common share of the Company (a "Common Share") (or Common Share equivalent) and one common share purchase warrant (each a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of Cdn$0.69 per Common Share at any time prior to the five-year anniversary of the closing date of the Private Placement (the "Closing Date").

維權生活方式與健康有限公司。(“激進派“或”公司") (CSE:冷靜) (場外交易:RVLWF) (FSE:4DO)欣然宣佈,已就私募配售單位訂立證券購買協議(“單位“)僅向機構投資者提供公司總計約300萬加元的總收益(”私募配售)。根據定向增發,本公司將發行5,357,143個單位,收購價為每單位0.56加元。每個單位將由一股本公司普通股(A)組成。普通股“)(或等值普通股)及一份普通股認購權證(每份認購權證均為”搜查令“)。每份認股權證持有人將有權在私募結束日期五年前的任何時間,以每股普通股0.69加元的行使價購買一股普通股(以下簡稱”認股權證“)。截止日期").


H.C. Wainwright & Co. is acting as the exclusive placement agent for the private placement in the United States.

H.C.温賴特公司(H.C.Wainwright&Co.)將擔任此次私募在美國的獨家配售代理。

The Common Shares and Warrants comprising the Units to be issued under the Private Placement will be qualified by way of a prospectus supplement under the Company's base shelf prospectus dated October 29, 2021 (collectively, the "Prospectus Supplement") which will be filed in each of the provinces of Canada, except Québec. In the United States, the Common Shares, Warrants and the shares issuable upon the exercise of the Warrants will be offered on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), and certain other jurisdictions in accordance with applicable securities laws.

組成根據私募發行的單位的普通股及認股權證,將根據本公司日期為二零二一年十月二十九日的基礎架子招股説明書(統稱為“認股書”),以招股説明書補充的方式獲得資格。招股説明書副刊將在加拿大各省(魁北克省除外)提交。在美國,普通股、認股權證和行使認股權證後可發行的股份將根據修訂後的1933年美國證券法的登記要求豁免以私募方式發行(美國證券法“),以及根據適用的證券法的某些其他司法管轄區。

The net proceeds of the Private Placement are expected to be used by the Company for working capital and general corporate purposes, including, without limitation, expansion of the number of clinics throughout North America, increase of corporate infrastructure to sustain the foregoing, acquisitions of assets used in the Company's business and strategic transactions and/or acquisitions. Details as to the specific allocation of the proceeds will be disclosed in the Prospectus Supplement.

私募的淨收益預計將用於營運資金和一般公司目的,包括但不限於北美各地診所數量的擴大、公司基礎設施的增加以維持上述目標、收購用於公司業務的資產以及戰略交易和/或收購。有關收益的具體分配細節將在招股説明書副刊中披露。

The Company expects the Closing Date to occur on or about November 17, 2021. The Company has applied to list the Common Shares issued in the Private Placement and the Common Shares underlying the Warrants on the Canadian Securities Exchange (the "CSE"). The Private Placement is subject to the satisfaction of certain customary closing conditions, including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals.

該公司預計截止日期為2021年11月17日左右。本公司已申請將私募發行的普通股及認股權證相關的普通股在加拿大證券交易所(“加拿大證券交易所”)掛牌上市。CSE“)。私募須符合若干慣常的成交條件,包括但不限於獲得所有必需的監管及證券交易所批准。

This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in Canada in connection with the Private Placement.

本新聞稿不應構成出售要約或徵求購買要約,也不應在加拿大任何司法管轄區出售與私募有關的任何證券。

This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This news release shall not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the U.S. Securities Act and such securities may not be offered or sold within the United States absent registration under U.S. federal and state securities laws or an applicable exemption from such U.S. registration requirements.

本新聞稿不應構成出售要約或徵求購買要約,也不應在任何司法管轄區的證券法律規定的註冊或資格之前將此類要約、招攬或出售視為非法的任何證券出售。本新聞稿不構成在美國出售證券的要約。正在發行的證券沒有,也不會根據美國證券法註冊,如果沒有根據美國聯邦和州證券法註冊或獲得美國此類註冊要求的適用豁免,此類證券可能不會在美國境內發行或銷售。

ABOUT REVITALIST LIFESTYLE AND WELLNESS

關於激進主義的生活方式和健康

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with five clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For more information, please visit www.revitalist.com or follow us at:

Reitist Lifestyle and Wellness Ltd.(CSE:CAME)(場外交易市場代碼:RVLWF)(FSE:4DO)是一家上市公司,總部設在田納西州諾克斯維爾,在美國各地有5家診所,而且還在不斷擴大。Revitist致力於通過醫療專業人員、心理健康專家和慢性疼痛專家提供的全面護理和以未來為中心的治療相結合的方式,增強個人的幸福感質量。自2018年開設第一家診所以來,Revitist已經為患有治療耐藥疾病的患者提供了數千次輸液。此外,Revitist還提供一些生活方式優化服務和維生素注射,讓任何人都能更接近完全健康。如需更多信息,請訪問www.retivalist.com或關注我們的網站:

Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd

推特:@RevitalistCorpFacebook:@RevitalistLifestyleandWellnessLtdInstagram:@RevitalistCorpLinkedIn:@RevitalistLifestyleAndWellnessLtd

Forward-Looking Statements

前瞻性陳述

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Forward-looking statements contained in this news release include statements regarding the closing of the Private Placement, the timing of the closing of the Private Placement, the use of proceeds from the Private Placement and the receipt of requisite regulatory approvals. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding looking wording such as "may", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward- looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, market and other conditions, volatility in the trading price of the Common Shares, risks relating to the ability of the Company to obtain the requisite regulatory approvals relating to the Private Placement, business, economic and capital market conditions; the ability to manage operating expenses, which may adversely affect the Company's financial condition; the ability to remain competitive as other better financed competitors develop and release competitive products; regulatory uncertainties; the ability to manage working capital; and the dependence on key personnel. Revitalist may not actually achieve its plans, projections, or expectations. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the demand for its products and services, the ability to successfully complete the acquisition of additional clinics, that there will be no regulation or law that will prevent the Company from operating its business, anticipated costs, the ability to secure sufficient capital to complete its business plans. Given these risks, uncertainties and assumptions, readers should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include, failure to obtain regulatory approval, the continued availability of capital and financing, the impact of Covid-19 or other viruses and diseases on the Company's ability to operate, secure equipment, and hire personnel, competition, potential litigation, increase in operating and labor costs, loss of key employees and consultants, and general economic, market or business conditions. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made by third parties in respect of the matters discussed above.

本新聞稿包含與公司業務計劃和公司行業前景相關的適用證券法所指的“前瞻性信息”。本新聞稿中包含的前瞻性陳述包括有關私募的結束、私募的結束時間、私募收益的使用以及獲得必要的監管批准的陳述。前瞻性陳述由非純粹的歷史性陳述組成,包括任何有關對未來的信念、計劃、期望或意圖的陳述。這樣的信息通常可以通過使用諸如“可能”、“預期”、“估計”、“預期”、“打算”、“相信”和“繼續”或其否定或類似變體的轉發字眼來標識。提醒讀者,在準備任何前瞻性信息時使用的假設可能被證明是不正確的。由於許多已知和未知的風險、不確定因素和其他因素,包括但不限於市場和其他條件、普通股交易價格的波動、與公司獲得與私募有關的必要監管批准的能力、商業、經濟和資本市場狀況、管理運營費用的能力,這可能對公司的財務狀況產生不利影響,事件或情況可能導致實際結果與預測的結果大不相同,其中許多因素是公司無法控制的,包括但不限於:市場和其他條件、普通股交易價格的波動、與公司獲得與私募有關的必要監管批准的風險、商業、經濟和資本市場條件;管理運營費用的能力,這可能對公司的財務狀況產生不利影響;在其他資金更充足的競爭對手開發和發佈有競爭力的產品時保持競爭力的能力;監管不確定性;管理營運資本的能力;以及對關鍵人員的依賴。革命者可能不會真正實現它的計劃,預測, 或者期望。這些陳述和信息基於對目前和未來的業務戰略以及公司未來經營環境的許多假設,包括對其產品和服務的需求、成功完成對更多診所的收購的能力、不會有任何法規或法律阻止公司經營業務、預期成本、獲得足夠資本以完成其業務計劃的能力。鑑於這些風險、不確定性和假設,讀者不應過度依賴這些前瞻性陳述。可能導致實際結果與前瞻性陳述中的結果大不相同的因素包括:未能獲得監管部門的批准、資本和融資的持續可獲得性、新冠肺炎或其他病毒和疾病對公司運營、保障設備安全和招聘人員能力的影響、競爭、潛在的訴訟、運營和勞動力成本的增加、關鍵員工和顧問的流失,以及總體經濟、市場或商業狀況。本新聞稿中包含的前瞻性陳述明確受本警告性聲明的限制。提醒讀者不要過度依賴任何前瞻性信息。本新聞稿中包含的前瞻性陳述是截至本新聞稿發佈之日作出的。除非法律另有要求,否則公司沒有任何意圖,也沒有義務更新或修改任何前瞻性陳述,無論是由於新信息、未來事件或其他原因。此外,本公司沒有義務對第三方對上述事項的期望或陳述發表評論。


Contacts
聯繫人

On Behalf of the Board
Kathryn Walker
Chief Executive Officer

我謹代表董事會凱瑟琳·沃克首席執行官

Revitalist Lifestyle and Wellness Ltd.
Email: IR@revitalist.com
Tel: (865) 585-8414

維權生活方式與健康有限公司。電子郵件:ir@revitalist.com電話:(865)585-8414

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論